J B Chemicals Pharmaceuticals Ltd vs Lyka Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of J B Chemicals & Pharmaceuticals Ltd is ₹ 2110 as of 18 May 11:57 . The P/E Ratio of J B Chemicals & Pharmaceuticals Ltd changed from 21.6 on March 2021 to 38.3 on March 2025 . This represents a CAGR of 12.14% over 5 yearsThe P/E Ratio of Lyka Labs Ltd changed from 10 on March 2022 to 45.1 on March 2025 . This represents a CAGR of 45.73% over 4 years The Market Cap of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 9688 crore on March 2021 to ₹ 25253 crore on March 2025 . This represents a CAGR of 21.12% over 5 yearsThe Market Cap of Lyka Labs Ltd changed from ₹ 74.59 crore on March 2021 to ₹ 360.29 crore on March 2025 . This represents a CAGR of 37.02% over 5 years The revenue of J B Chemicals & Pharmaceuticals Ltd for the Mar '26 is ₹ 916.21 crore as compare to the Dec '25 revenue of ₹ 1083 crore. This represent the decline of -15.4% The revenue of Lyka Labs Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 31.89 crore. This represent the decline of -100% The ebitda of J B Chemicals & Pharmaceuticals Ltd for the Mar '26 is ₹ 185.93 crore as compare to the Dec '25 ebitda of ₹ 314.1 crore. This represent the decline of -40.81% The ebitda of Lyka Labs Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 2.81 crore. This represent the decline of -100% The net profit of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 176.83 crore to ₹ 101.37 crore over 8 quarters. This represents a CAGR of -24.29% The net profit of Lyka Labs Ltd changed from ₹ 1.29 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of J B Chemicals & Pharmaceuticals Ltd changed from 28.53 % on March 2021 to 36.98 % on March 2025 . This represents a CAGR of 5.33% over 5 yearsThe Dividend Payout of Lyka Labs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About J B Chemicals & Pharmaceuticals Ltd

J B Chemicals & Pharmaceuticals Limited (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals on December 18, 1976.
The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and Active Pharmaceutical Ingredients (APIs).
The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman.
The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.'95.
Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) form a significant part of the company's sales.

About Lyka Labs Ltd

Initially manufacturing formulations, Lyka Labs Limited brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr. '83.
It also added a range of ayurvedic and animal health care products over the years.
In 1990, it diversified into marketing medical and diagnostic equipment and instruments of Bekton Dickinson, US; Airsep Corporation, US; Coloplast, Denmark; and Terumo Corporation, Japan.
Lyka Exports is the subsidiary of the company.
The Company is engaged in the development, manufacture and marketing of quality finished dosages. The company offers a broad range of antibiotics used as life-savers and to treat minor infections.

FAQs for the comparison of J B Chemicals & Pharmaceuticals Ltd and Lyka Labs Ltd

Which company has a larger market capitalization, J B Chemicals & Pharmaceuticals Ltd or Lyka Labs Ltd?

Market cap of J B Chemicals & Pharmaceuticals Ltd is 34,313 Cr while Market cap of Lyka Labs Ltd is 219 Cr

What are the key factors driving the stock performance of J B Chemicals & Pharmaceuticals Ltd and Lyka Labs Ltd?

The stock performance of J B Chemicals & Pharmaceuticals Ltd and Lyka Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for J B Chemicals & Pharmaceuticals Ltd and Lyka Labs Ltd?

As of May 18, 2026, the J B Chemicals & Pharmaceuticals Ltd stock price is INR ₹2137.15. On the other hand, Lyka Labs Ltd stock price is INR ₹61.5.

How do dividend payouts of J B Chemicals & Pharmaceuticals Ltd and Lyka Labs Ltd compare?

To compare the dividend payouts of J B Chemicals & Pharmaceuticals Ltd and Lyka Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.